Operator of a pharmaceutical company developing inhalation treatments for severe chronic and recurrent pulmonary infections. The company is developing a drug for the treatment of Nontuberculous Mycobacteria (NTM) and Tuberculosis.
What you see here scratches the surface
We’ll help you find what you need
This information is available in the PitchBook Platform. To explore QrumPharma‘s full profile, request access.
© 2021 PitchBook Data. All rights reserved. PitchBook is a financial technology company that provides data on the capital markets.